Critical involvement of the phosphatidylinositol 3-kinase/Akt pathway in anchorage-independent growth and hematogeneous intrahepatic metastasis of liver cancer
- PMID: 12019180
Critical involvement of the phosphatidylinositol 3-kinase/Akt pathway in anchorage-independent growth and hematogeneous intrahepatic metastasis of liver cancer
Abstract
In the multistep process of metastasis, "anchorage-independent growth," where cancer cells need to survive without cell-substratum interaction, is supposed to be important. In this study, we found that anchorage-independent growth analyzed using the soft agar colony formation assay correlated with hematogeneous intrahepatic metastasis of liver cancer cell lines and also Akt activation status. Two highly metastatic liver cancer cell lines showed high Akt activity and formed many colonies in soft agar, whereas three nonmetastatic cell lines showed less Akt activity and formed fewer colonies. Inhibition of Akt activation in the highly metastatic cell line Li7 by transfection with kinase-dead Akt or the phosphatidylinositol 3-kinase inhibitor, LY294002, resulted in formation of fewer colonies in soft agar than was the case with control cells. Moreover, in orthotopic implantation model, this inhibition resulted in a reduced rate of hematogeneous intrahepatic metastasis. These findings indicated that anchorage-independent growth regulated by phosphatidylinositol 3-kinase/Akt pathway plays a critical role in metastasis, and that this could be a potential therapeutic target to combat metastasis.
Similar articles
-
ErbB2-overexpressing human mammary carcinoma cells display an increased requirement for the phosphatidylinositol 3-kinase signaling pathway in anchorage-independent growth.Oncogene. 2001 Nov 8;20(51):7551-62. doi: 10.1038/sj.onc.1204964. Oncogene. 2001. PMID: 11709727
-
CRBP suppresses breast cancer cell survival and anchorage-independent growth.Oncogene. 2001 Nov 1;20(50):7413-9. doi: 10.1038/sj.onc.1204749. Oncogene. 2001. PMID: 11704871
-
Cooperative effect of hepatocyte growth factor and fibronectin in anchorage-independent survival of mammary carcinoma cells: requirement for phosphatidylinositol 3-kinase activity.Cell Growth Differ. 2000 Feb;11(2):123-33. Cell Growth Differ. 2000. PMID: 10714768
-
Cell adhesion molecules in the formation of liver metastasis.J Hepatobiliary Pancreat Surg. 1998;5(4):375-82. doi: 10.1007/s005340050061. J Hepatobiliary Pancreat Surg. 1998. PMID: 9931386 Review.
-
Phosphatidylinositol 3-kinases in tumor progression.Eur J Biochem. 2001 Feb;268(3):487-98. doi: 10.1046/j.1432-1327.2001.01936.x. Eur J Biochem. 2001. PMID: 11168386 Review.
Cited by
-
Novel lncRNA SFTA1P Promotes Tumor Growth by Down-Regulating miR-4766-5p via PI3K/AKT/mTOR Signaling Pathway in Hepatocellular Carcinoma.Onco Targets Ther. 2020 Sep 30;13:9759-9770. doi: 10.2147/OTT.S248660. eCollection 2020. Onco Targets Ther. 2020. PMID: 33061455 Free PMC article.
-
The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigation.Anesth Analg. 2011 Mar;112(3):558-67. doi: 10.1213/ANE.0b013e31820568af. Epub 2010 Dec 14. Anesth Analg. 2011. PMID: 21156980 Free PMC article.
-
CREB3L1 is a metastasis suppressor that represses expression of genes regulating metastasis, invasion, and angiogenesis.Mol Cell Biol. 2013 Dec;33(24):4985-95. doi: 10.1128/MCB.00959-13. Epub 2013 Oct 14. Mol Cell Biol. 2013. PMID: 24126059 Free PMC article.
-
Inflammatory interferon activates HIF-1α-mediated epithelial-to-mesenchymal transition via PI3K/AKT/mTOR pathway.J Exp Clin Cancer Res. 2018 Mar 27;37(1):70. doi: 10.1186/s13046-018-0730-6. J Exp Clin Cancer Res. 2018. PMID: 29587825 Free PMC article.
-
The anti-migration and anti-invasion effects of Bruceine D in human triple-negative breast cancer MDA-MB-231 cells.Exp Ther Med. 2020 Jan;19(1):273-279. doi: 10.3892/etm.2019.8187. Epub 2019 Nov 12. Exp Ther Med. 2020. PMID: 31853299 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical